Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. The drugmaker is ...
The Well News on MSNOpinion
How to lower health costs and improve access
In April, members of Congress questioned hospital CEOs about the rising cost of health care - and particularly criticized ...
Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not ...
Eli Lilly said last night it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation ...
Three hospitals have sued CVS Health alleging the company redirected $250 million in savings from the 340B program. Mount Sinai Hospital, including St. Luke's-Roosevelt Hospital and Mount Sinai Beth ...
When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients ...
This appeal concerns Maine's effort to use state law to impose additional obligations on drug manufacturers who participate ...
Hospitals affiliated with Mount Sinai, the University of Michigan and the University of Kansas allege that CVS artificially ...
Effective compliance now spans transaction eligibility, OPAIS synchronization, Medicaid exclusion validation, cost-report ...
With post-pandemic Medicaid enrollments on the decline and expected to fall further, revenue cycle leaders warn that ...
Three health systems are suing CVS Health, alleging the company and its pharmacy subsidiaries diverted roughly $250 million in savings from the 340B Drug Pricing Program. The 340B program was ...
The 340B program allows eligible clinics to purchase medications at a substantial discount, at no cost to taxpayers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results